Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06272318 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Vital Signs Blood Pressure Trial

StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status changed: Not Yet Recruiting → Active, Not Recruiting Show 5 more changesShow less
    • Primary completion date changed from estimate of Sep 30, 2026 to Aug 28, 2026
    • Study completion pushed from Sep 30, 2026 to Dec 30, 2026
    • Study sites: 0 to 1
    • Start date changed from estimate of May 1, 2026 to May 4, 2026
    • Eligibility criteria shortened, about 8 words
  2. Start date: Sep 1, 2025 to May 1, 2026v6
  3. Primary completion date: Jun 30, 2025 to Sep 30, 2026
    • Start date: Jan 1, 2025 to Sep 1, 2025
    • Study completion date: Dec 31, 2026 to Sep 30, 2026
    v5
  4. Start date: Aug 1, 2024 to Jan 1, 2025v4
  5. Primary completion date: Jun 30, 2024 to Jun 30, 2025
    • Start date: Jun 1, 2024 to Aug 1, 2024
    v3
  6. Start date: Feb 20, 2024 to Jun 1, 2024
    • Primary endpoints revised (8)
    v2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Stanford University
634 trials monitored
See 47 trials at risk
Heart Disease
8,786 trials monitored
See 412 trials at risk
Hypertension
1,925 trials monitored
See 99 trials at risk
The purpose of this study is collect subject vitals with a blood pressure cuff, electrocardiogram (ECG), and photoplethysmogram (PPG). This data can then be used to develop a reliable, accurate, noninvasive, and continuous blood pressure monitoring device.
Trial Details
NCT Number NCT06272318
Lead Sponsor Stanford University
Conditions
(from sponsor)		 Cardiovascular Diseases, Hypertension, Blood Pressure
Related terms Cardiovascular Diseases, Hypertension
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov